Company Details
- Employees
- 110
- Address
- 151 Oyster Point Blvd, South San Francisco,ca 94080,united States
- Phone
- 6503510353
- Industry
- Biotechnology
- Website
- cytomx.com
- HQ
- South San Francisco, CA
Please complete the CAPTCHA to continue
Related company profiles:
CytomX Therapeutics Appoints Rachael Lester as Chief Business Officer Yahoo Finance
CytomX Therapeutics Appoints Rachael Lester as Senior Vice President, Chief Business Officer Quiver Quantitative
CytomX (Nasdaq: CTMX) appoints Rachael Lester CBO to lead strategy and partnerships Stock Titan
CytomX Therapeutics Reports Promising Interim Phase 1 Data for CX-2051 in Advanced Colorectal Cancer with Plans for Phase 2 Study Initiation Nasdaq
CytomX Therapeutics to Report Second Quarter 2025 Financial Results on August 7, 2025 Yahoo Finance
CytomX Therapeutics Sets Q2 Earnings Date: Biotech Leader to Update on Masked Biologics Progress Stock Titan
CytomX Therapeutics Doses First Patient in Phase 1 Study of CX-801 Combined with KEYTRUDA® for Metastatic Melanoma Quiver Quantitative
CytomX Therapeutics to Present at Upcoming September Investor Conferences Yahoo Finance
CytomX Earnings: Breakthrough Colorectal Cancer Drug Shows Promise as Company Raises $100M Stock Titan
CytomX Therapeutics Provides Update on CX-2051 Phase 1 Study Yahoo Finance
CytomX Therapeutics Focuses on Lead Program CX-2051 and Streamlines Operations for 2025 Quiver Quantitative
CytomX Therapeutics CEO Set for Jefferies Conference: Key Biologics Updates Coming Stock Titan
CytomX Therapeutics Announces Second Quarter 2025 Financial Results and Provides Business Update Yahoo Finance
CytomX Cancer Drug Trial Continues Despite Patient Death, Phase 1 Data Expected Q1 2026 Stock Titan
Biotech Leader CytomX Sets Q1 2025 Earnings Date: Key Details for Investors Stock Titan
CytomX Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock Yahoo Finance
CytomX Therapeutics Announces First Quarter 2025 Financial Results and Provides Business Update Stock Titan
CytomX Unveils Breakthrough Cancer Treatment Data with Moderna at AACR | CTMX Stock News Stock Titan
CytomX Therapeutics to Present at Upcoming September Investor Conferences Stock Titan
CytomX has a tox wobble | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
Do CytomX Therapeutics' (NASDAQ:CTMX) Earnings Warrant Your Attention? Yahoo Finance
Why CytomX Therapeutics Stock Was Skyrocketing This Week The Motley Fool
CytomX shifts towards EpCAM | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
CytomX reports patient death from kidney injury in ADC trial Fierce Biotech
Deals mask CytomX’s fundamental problem | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
CytomX: A Fresh Start With New Drugs After Total Pipeline Failure (NASDAQ:CTMX) Seeking Alpha
John A. Scarlett, M.D. Retires From CytomX Therapeutics Board citybiz
CytomX Therapeutics: Updated Outlook For Late 2025 (NASDAQ:CTMX) Seeking Alpha
CytomX Therapeutics Announces $30 Million Private Placement from BVF Partners L.P. Stock Titan
CytomX delivers a pancreatic surprise | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
CytomX Reports Treatment-Related Patient Death in Phase I Colorectal Cancer Study BioSpace
CX-2051 Demonstrates Preliminary Activity in Heavily Pretreated Advanced Colorectal Cancer OncLive
CTMX.O - | Stock Price & Latest News Reuters
CytomX Therapeutics: Doubling Overnight On Phase 1 Data... Still Bullish? Seeking Alpha
CytomX to Cut 40% of Staff as It Updates Pipeline Priorities BioSpace
Amgen and CytomX throw off masked T-cell engager, axing asset after assessing data, priorities Fierce Biotech
Bay Area biotech firm CytomX, once worth $1.2 billion, lays off 40% of staff SFGATE
Moderna signs $35 million deal with cancer drug developer CytomX Reuters
CytomX slashes headcount by 40% after breast cancer setback, with later-stage development bearing the brunt Fierce Biotech
Regeneron, CytomX Ink Potentially $2B Bispecific Immunotherapy Deal (Updated) BioSpace
Targeting CD166 Represents a New Avenue of Attack for Breast Cancer OncLive
CytomX Therapeutics Inc (CTMX) Stock Price, Trades & News GuruFocus
CTMX - Cytomx Therapeutics Inc Latest Stock News & Market Updates Stock Titan
CTMX Stock Price and Chart — NASDAQ:CTMX TradingView
FierceBiotech's 2013 Fierce 15 Fierce Biotech
1 (800) 9XXXXXXX
3 +161758XXXXX
Find emails, phones & company data instantly
Your AI prospecting assistant
0 records × $0.02 per record
Secure checkout
Total price
$0.50
Enter your payment details below to complete the download. We'll email you the CSV as soon as it's ready.
Processing your payment...
Please wait while we complete your transaction
Sign in required
Create a free account or sign in to continue downloading the full results.
Sign up for a free account. No credit card required. Up to 10 free credits.
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.